Pasithea Therapeutics Corp. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Pasithea Therapeutics Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Pasithea Therapeutics Corp. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 1.04M shares, a 17% decline year-over-year.
  • Pasithea Therapeutics Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.23M shares, a 2.83% decline from 2022.
  • Pasithea Therapeutics Corp. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.26M shares, a 87.9% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.04M -214K -17% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 1.04M -263K -20.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 1.04M -261K -20% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.23M -35.7K -2.83% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 1.26M -25.3M -95.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 1.31M -22.1M -94.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 1.3M -21.7M -94.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 1.26M -9.14M -87.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 26.5M +17.6M +196% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 23.4M +15.2M +184% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 23M +15.1M +189% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 10.4M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 8.96M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 8.26M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 7.95M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.